Literature DB >> 16642253

Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27.

Carol Beadling1, Mark K Slifka.   

Abstract

The functional characterization and subsequent purification of T cell growth factor/interleukin (IL)-2 in the early 1980s established this secreted protein as a key mediator of immune cell activation and provided the prototype that enabled the discovery of numerous cytokines over the ensuing two decades. While soluble immunoregulatory factors were initially identified functionally as biological activities present in the culture supernatants of activated lymphocytes/monocytes, this methodology shifted radically following the completion of the human genome sequence. Computer-generated structural modeling algorithms have replaced functional assays and biochemical purification as the initial means of discovering new cytokines. To date, a total of 31 interleukins, as well as over a dozen other related hematopoietic factors, have been identified. These cytokines and their receptors may be grouped on the basis of structural homologies as well as by shared ligand and receptor subunits. The challenge now at hand is to define the biological functions of the newly identified cytokines and to elucidate the common and divergent roles of related family members. This point is well illustrated by the IL-12/IL-23/IL-27 family, whose members share ligand and receptor subunits and play somewhat overlapping roles in innate and adaptive immune responses. These three cytokines are not entirely redundant, as they may preferentially activate naïve or memory T cells, induce discrete T cell cytokine profiles, contribute to distinct stages of host immune responses to infectious agents, and differentially promote autoimmunity. Further elucidation of the unique functions of the IL-12 family members may lead to improved immunodiagnostics and therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642253     DOI: 10.1007/s00005-006-0002-6

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  30 in total

1.  Regulation of innate CD8+ T-cell activation mediated by cytokines.

Authors:  Bailey E Freeman; Erika Hammarlund; Hans-Peter Raué; Mark K Slifka
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.

Authors:  Maya Eisenring; Johannes vom Berg; Glen Kristiansen; Elisabeth Saller; Burkhard Becher
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

Review 3.  Perspective is everything: an irreverent discussion of CNS-immune system interactions as viewed from different scientific traditions.

Authors:  Monica J Carson; David D Lo
Journal:  Brain Behav Immun       Date:  2007-01-17       Impact factor: 7.217

Review 4.  Interleukin-23 as a potential therapeutic target for rheumatoid arthritis.

Authors:  Chao Rong; Wei Hu; Fan-rong Wu; Xiao-juan Cao; Fei-hu Chen
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

5.  The presence of interleukin-27 during monocyte-derived dendritic cell differentiation promotes improved antigen processing and stimulation of T cells.

Authors:  Joo-Yong Jung; Lawton L Roberts; Cory M Robinson
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

6.  Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection.

Authors:  Jing Ma; Jinghua Wang; Jing Wan; Richard Charboneau; Yaping Chang; Roderick A Barke; Sabita Roy
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

Review 7.  Interleukin-23: as a drug target for autoimmune inflammatory diseases.

Authors:  Chunlei Tang; Shu Chen; Hai Qian; Wenlong Huang
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

Review 8.  Interleukin 12 a key immunoregulatory cytokine in infection applications.

Authors:  Therwa Hamza; John B Barnett; Bingyun Li
Journal:  Int J Mol Sci       Date:  2010-02-26       Impact factor: 5.923

9.  Anti-inflammatory cytokines directly inhibit innate but not adaptive CD8+ T cell functions.

Authors:  Bailey E Freeman; Christine Meyer; Mark K Slifka
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

10.  3,3'-Diindolylmethane stimulates murine immune function in vitro and in vivo.

Authors:  Ling Xue; James J Pestka; Maoxiang Li; Gary L Firestone; Leonard F Bjeldanes
Journal:  J Nutr Biochem       Date:  2007-08-17       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.